BBTX

Bambusa Therapeutics, Inc. · Healthcare

Insiders bought $12.0M net in the last 90 days ·0 sellers, 2 buyers· latest Form 4 filed Nov 2, 2026

Insider Buying

$12.0M

reported purchases (SEC code P)

Insider Selling

$0

reported sales (SEC code S)

Unique Insiders

2

in the rolling window

Latest filing

Nov 2, 2026

Salvia Investment GmbH

Bambusa Therapeutics, Inc. (BBTX) has 3 SEC Form 4 filings (6 transaction rows) in the rolling window, disclosed by 2 distinct insiders. Most recent filing: Nov 2, 2026.

Inside the rolling window, 2 insiders at Bambusa Therapeutics, Inc. reported 2 open-market purchases totaling $12.0M and no open-market sales. Insiders have net bought $12.0M over the trailing 6 months. The largest single insider purchase in this window was $6.0M by 10% Owner Salvia Investment GmbH on Nov 2, 2026.

  • Industry:Biotechnology
  • CEO:Shan Shan Xu
  • Employees:26
  • HQ:Boston, MA, US
  • IPO:2026-10-30
Source
Purchase$6.0MNov 2SEC ↗
Purchase$6.0MNov 2SEC ↗
Showing 1–2 of 2
1 / 1

Frequently asked questions

How many SEC Form 4 insider filings does BBTX have?

Bambusa Therapeutics, Inc. (BBTX) has 3 SEC Form 4 filings (6 transaction rows) in the rolling 365-day window, disclosed by 2 distinct insiders. Most recent filing: Nov 2, 2026.

When was the most recent SEC Form 4 filing for BBTX?

The most recent Form 4 filing for BBTX on Tracefour is dated Nov 2, 2026.

What is the net insider flow at BBTX over the last 6 months?

Over the trailing 180 days, insiders at BBTX have net bought $12.0M based on SEC Form 4 disclosures.

What was the largest insider purchase at BBTX?

The largest single insider open-market purchase at BBTX in the rolling window was $6.0M by 10% Owner Salvia Investment GmbH on 2026-11-02.

What is the total insider buy and sell value at BBTX in the current window?

Inside the rolling window, insiders at BBTX bought $12.0M and sold $0 based on SEC Form 4 filings.

Can I get alerts for BBTX insider trading?

Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at Bambusa Therapeutics, Inc. (BBTX). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.

Related companies

Bambusa Therapeutics, Inc. is in the Healthcare sector.